Assignee
MYR GMBH
DE·1 granted patent·3 pending applications·2 citations·filing 2015–2021
Top patents by PatentIndex Score
4 records- 0170US10925925B2Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitorsMYR GMBH·Filed 2018·Granted Feb 23, 2021·2 cites·18 claims
- 0253US2022040178A1Combination therapy of hbv and hdv infectionMYR GMBH·Filed 2021·Application pending·0 cites
- 0351US2021196786A1Therapy of atherosclerosis, primary biliary cirrhosis and nrlp3 inflammasome-associated disease by htcp inhibitorsMYR GMBH·Filed 2021·Application pending·0 cites
- 0433US2018228804A1Combination therapy of hbv and hdv infectionMYR GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MYR GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →